Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    15998894 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients
Condition: Sickle Cell Disease
Intervention: Drug: RAS Inhibitors
2 Completed Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria
Conditions: Secondary Pulmonary Arterial Hypertension;   Sickle Cell Disease;   Pulmonary Hypertension
Intervention:
3 Unknown  Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
Condition: Sickle Cell Disease
Intervention:

Indicates status has not been verified in more than two years